Multicenter, Open-label, Phase 1, Dose-escalation,Cohort-expansion, First-in-Human Study of KHK2455 Administered as Monotherapy and in Combination with Mogamulizumab (KW-0761) in Adult Subjects with Locally Advanced or Metastatic Solid Tumors
A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects with Metastatic Urothelial Cancer and Other Malignant Solid Tumors that Express Nectin-4
Thank you for your interest in scheduling an appointment with our expert team. Please call us at 1-888-663-3488 and a patient services specialist can assist you with scheduling or click on one of the links below to fill out our convenient online form.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
RETURNING PATIENTS Since you are an established Moffitt patient, please call us directly to schedule your follow-up appointment at 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.